Mathieu Ghadanfar, MD, FESC, FAHA
Pierre and Marie Curie University
Tell me more about Mathieu Ghadanfar, MD, FESC, FAHA?
Mathieu Ghadanfar, MD, FESC, FAHA is a highly experienced cardiovascular physician, biotech, and pharmaceutical executive with 27.8 years of work experience. He has held leadership and management roles for internationally renowned pharmaceutical companies, specializing in clinical trials, drug development, and global medical affairs. Currently serving as the Chief Medical Officer (remote), Mathieu is responsible for developing transformative vaccines based on messenger RNA (mRNA) for infectious diseases. He has successfully launched multiple assets, including LCZ 696 and Aliskiren, and has successfully managed multiple outcomes trials for hypertension, renal protection, and cardiovascular risk reduction. Mathieu is known for his excellent communication and collaboration skills, leadership,
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Throughout my career as a cardiovascular physician, biotech, and pharmaceutical executive, I have had repeated success in leadership and management roles. With considerable experience working for internationally renowned pharmaceutical companies, my expertise is broad and ranges from clinical trials and drug development to Global medical affairs, scientific excellence, marketing, and launches, all on a global scale and across multiple therapy areas, including hypertension, cardiology, renal, diabetes, and atherosclerosis. I currently serve as Chief Medical Officer (remote), and on the management team at Ziphius Vaccines a self-amplifying RNA company developing transformative vaccines based on messenger RNA (mRNA) for the prevention of infectious diseases. As a consultant specializing in life sciences, I bring not only my professional experience but excellent communication and collaboration skills, leadership, strategic thinking, combined with proven success in guiding complex and large-scale projects worldwide. I have worked and lived in France, Switzerland, the UK, and the USA, which has provided me with a strong knowledge of regulatory agencies, health care systems both in the US and internationally. Please note some of the following highlights from my career: ♦︎ Established and led the Medical and Scientific Excellence Group for Global Medical Affairs ♦︎ Acted as deputy to the Global Head Medical Affairs and Chief Medical Office Pharma ♦︎ Successful launches for multiple assets, including LCZ 696 - Entresto® in heart failure, and the development, approvals, and launches of Aliskiren (Rasilez®) and its fixed-dose combinations. ♦︎ Managed multiple large and complex, multi-site outcomes trials for hypertension, renal protection, and cardiovascular risk reduction as well as the clinical development and the launch of Caduet® (Norvasc®+Lipitor® combination) for CV risk reduction. As a consultant, I will work to bring the same level of success to you. I look forward to connecting with you so we can discuss in further detail how my skills and experience can be put to work for you.
...See MoreWork Experience
innovative pharma & biotech visionary | strategic chief medical officer | cardiovascular physician specialist
President
Mathieu Ghadanfar, MD, FESC, FAHA's Professional Milestones
- Chief Marketing Officer (2020-01-01~): Launching successful marketing campaigns that drive brand awareness and increase customer engagement.
- Chief Medical Officer And Member Of The Executive Committee (2020-01-01~): Transformed the healthcare program, enhancing patient care and gaining meaningful impact in the executive committee.
Education
Echocardiography,
Pharmacology And Methodology Of Clinical Trials
Certification
Colleagues
Other Named Mathieu Ghadanfar, MD, FESC, FAHA
Frequently asked questions
We found 3 Mathieu Ghadanfar, MD, FESC, FAHA's email addresses
Mathieu Ghadanfar, MD, FESC, FAHA's social media include: Linkedin,
Mathieu Ghadanfar, MD, FESC, FAHA works for M-Ghadanfar Consulting (Life Sciences)
Mathieu Ghadanfar, MD, FESC, FAHA's role in M-Ghadanfar Consulting (Life Sciences) is innovative pharma & biotech visionary | strategic chief medical officer | cardiovascular physician specialist
Mathieu Ghadanfar, MD, FESC, FAHA's colleagues are Mathieu Ghadanfar, MD, FESC, FAHA
Mathieu Ghadanfar, MD, FESC, FAHA's latest job experience is innovative pharma & biotech visionary | strategic chief medical officer | cardiovascular physician specialist at M-Ghadanfar Consulting (Life Sciences)
Mathieu Ghadanfar, MD, FESC, FAHA's latest education in Pierre and Marie Curie University